- Home
- BZUN vs CRVO Comparison
BZUN vs CRVO Comparison
Compare BZUN & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- CRVO
- Stock Information
- Founded
- BZUN 2007
- CRVO 2001
- Country
- BZUN China
- CRVO United States
- Employees
- BZUN N/A
- CRVO N/A
- Industry
- BZUN Catalog/Specialty Distribution
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- BZUN Consumer Discretionary
- CRVO Health Care
- Exchange
- BZUN Nasdaq
- CRVO Nasdaq
- Market Cap
- BZUN 166.3M
- CRVO 160.4M
- IPO Year
- BZUN N/A
- CRVO N/A
- Fundamental
- Price
- BZUN $2.58
- CRVO $16.33
- Analyst Decision
- BZUN Buy
- CRVO Strong Buy
- Analyst Count
- BZUN 2
- CRVO 4
- Target Price
- BZUN $2.20
- CRVO $58.25
- AVG Volume (30 Days)
- BZUN 217.7K
- CRVO 79.5K
- Earning Date
- BZUN 08-28-2024
- CRVO 11-11-2024
- Dividend Yield
- BZUN N/A
- CRVO N/A
- EPS Growth
- BZUN N/A
- CRVO N/A
- EPS
- BZUN N/A
- CRVO N/A
- Revenue
- BZUN $1,235,027,314.00
- CRVO $9,653,281.00
- Revenue This Year
- BZUN $5.22
- CRVO $47.04
- Revenue Next Year
- BZUN $5.32
- CRVO N/A
- P/E Ratio
- BZUN N/A
- CRVO N/A
- Revenue Growth
- BZUN 5.56
- CRVO 585.67
- 52 Week Low
- BZUN $1.90
- CRVO $4.28
- 52 Week High
- BZUN $3.51
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- BZUN 63.75
- CRVO 52.18
- Support Level
- BZUN $2.23
- CRVO $15.94
- Resistance Level
- BZUN $2.49
- CRVO $20.63
- Average True Range (ATR)
- BZUN 0.11
- CRVO 1.88
- MACD
- BZUN 0.03
- CRVO 0.02
- Stochastic Oscillator
- BZUN 95.35
- CRVO 39.52
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.